Literature DB >> 21876117

Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression.

Victor R Gordeuk1, Galina Y Miasnikova, Adelina I Sergueeva, Xiaomei Niu, Mehdi Nouraie, Daniel J Okhotin, Lydia A Polyakova, Tatiana Ammosova, Sergei Nekhai, Tomas Ganz, Josef T Prchal.   

Abstract

Hypoxia is known to reduce the expression of hepcidin, the master regulator of iron metabolism. However, it is not clear whether this response is primarily related to increased erythropoiesis driven by hypoxically stimulated erythropoietin or to a more direct effect of hypoxia on hepcidin expression. The germline loss-of-function VHL(R200W) mutation is common in Chuvashia, Russia, and also occurs elsewhere. VHL(R200W) homozygotes have elevated hypoxia-inducible factor 1α (HIF-1α) and HIF-2α levels, increased red cell mass, propensity to thrombosis, and early mortality. Ninety VHL(R200W) homozygotes and 52 controls with normal VHL alleles from Chuvashia, Russia, were studied under basal circumstances. In univariate analyses, serum hepcidin concentration was correlated positively with serum ferritin concentration and negatively with homozygosity for VHL(R200W). After adjustment for serum erythropoietin and ferritin concentrations by multiple linear regression, the geometric mean (95% confidence interval of mean) hepcidin concentration was 8.1 (6.3-10.5) ng/mL in VHL(R200W) homozygotes versus 26.9 (18.6-38.0) ng/mL in controls (P < .001). In contrast, a significant independent relationship of serum erythropoietin, hemoglobin, or RBC count with hepcidin was not observed. In conclusion, up-regulation of the hypoxic response leads to decreased expression of hepcidin that may be independent of increased erythropoietin levels and increased RBC counts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21876117      PMCID: PMC3217409          DOI: 10.1182/blood-2011-03-345512

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  The worldwide distribution of the VHL 598C>T mutation indicates a single founding event.

Authors:  Enli Liu; Melanie J Percy; Christopher I Amos; Yongli Guan; Sanjay Shete; David W Stockton; Mary F McMullin; Lydia A Polyakova; Sonny O Ang; Yves D Pastore; Katerina Jedlickova; Terry R J Lappin; Victor Gordeuk; Josef T Prchal
Journal:  Blood       Date:  2003-11-06       Impact factor: 22.113

Review 2.  HIF hydroxylation and the mammalian oxygen-sensing pathway.

Authors:  Michal Safran; William G Kaelin
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

3.  Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia.

Authors:  Sonny O Ang; Hua Chen; Kiichi Hirota; Victor R Gordeuk; Jaroslav Jelinek; Yongli Guan; Enli Liu; Adelina I Sergueeva; Galina Y Miasnikova; David Mole; Patrick H Maxwell; David W Stockton; Gregg L Semenza; Josef T Prchal
Journal:  Nat Genet       Date:  2002-11-04       Impact factor: 38.330

4.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

5.  Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry.

Authors:  Melanie J Percy; Mary Frances McMullin; Simon N Jowitt; Michael Potter; Marilyn Treacy; William H Watson; Terence R J Lappin
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

6.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

7.  Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

Authors:  Elizabeta Nemeth; Marie S Tuttle; Julie Powelson; Michael B Vaughn; Adriana Donovan; Diane McVey Ward; Tomas Ganz; Jerry Kaplan
Journal:  Science       Date:  2004-10-28       Impact factor: 47.728

8.  Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors.

Authors:  Victor R Gordeuk; Adelina I Sergueeva; Galina Y Miasnikova; Daniel Okhotin; Yaroslav Voloshin; Peter L Choyke; John A Butman; Katerina Jedlickova; Josef T Prchal; Lydia A Polyakova
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

9.  HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface.

Authors:  Anthony M Giannetti; Pamela J Björkman
Journal:  J Biol Chem       Date:  2004-03-31       Impact factor: 5.157

10.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.

Authors:  Elizabeta Nemeth; Seth Rivera; Victoria Gabayan; Charlotte Keller; Sarah Taudorf; Bente K Pedersen; Tomas Ganz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more
  19 in total

Review 1.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

Review 2.  Regulation of erythropoiesis by hypoxia-inducible factors.

Authors:  Volker H Haase
Journal:  Blood Rev       Date:  2013-01-03       Impact factor: 8.250

Review 3.  Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2017-05-05       Impact factor: 3.905

4.  Treatment of erythropoietin deficiency in mice with systemically administered siRNA.

Authors:  William Querbes; Roman L Bogorad; Javid Moslehi; Jamie Wong; Amy Y Chan; Elena Bulgakova; Satya Kuchimanchi; Akin Akinc; Kevin Fitzgerald; Victor Koteliansky; William G Kaelin
Journal:  Blood       Date:  2012-05-18       Impact factor: 22.113

Review 5.  Hypoxia-inducible factors link iron homeostasis and erythropoiesis.

Authors:  Yatrik M Shah; Liwei Xie
Journal:  Gastroenterology       Date:  2013-12-31       Impact factor: 22.682

6.  HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling.

Authors:  Sadeesh K Ramakrishnan; Huabing Zhang; Shogo Takahashi; Brook Centofanti; Sarvesh Periyasamy; Kevin Weisz; Zheng Chen; Michael D Uhler; Liangyou Rui; Frank J Gonzalez; Yatrik M Shah
Journal:  Cell Metab       Date:  2016-02-04       Impact factor: 27.287

Review 7.  Anaemia in kidney disease: harnessing hypoxia responses for therapy.

Authors:  Mark J Koury; Volker H Haase
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

8.  Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells.

Authors:  Wen Guo; Eric Bachman; Michelle Li; Cindy N Roy; Jerzy Blusztajn; Siu Wong; Stephen Y Chan; Carlo Serra; Ravi Jasuja; Thomas G Travison; Martina U Muckenthaler; Elizabeta Nemeth; Shalender Bhasin
Journal:  Aging Cell       Date:  2013-02-28       Impact factor: 9.304

9.  The hypoxia-inducible factor-C/EBPα axis controls ethanol-mediated hepcidin repression.

Authors:  Erik R Anderson; Matthew Taylor; Xiang Xue; Angelical Martin; David S Moons; M Bishr Omary; Yatrik M Shah
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

Review 10.  Iron homeostasis in the liver.

Authors:  Erik R Anderson; Yatrik M Shah
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.